<DOC>
	<DOCNO>NCT00613574</DOCNO>
	<brief_summary>At moment , hardly structure safety efficacy data collection Tiotropium Russia . Therefore , objective observational study collect evaluate data bronchodilator efficacy safety Spiriva® ( 18 µg tiotropium inhalation capsule ) deliver HandiHaler® , national sample Russian patient vary severity chronic obstructive pulmonary disease ( COPD ) real life set 8 week .</brief_summary>
	<brief_title>RUSSE / Russian Spiriva® Safety &amp; Efficacy Study</brief_title>
	<detailed_description>The objective observational study collect evaluate data bronchodilator efficacy safety Spiriva® ( 18 µg tiotropium inhalation capsule ) deliver HandiHaler® , national sample Russian patient vary severity chronic obstructive pulmonary disease ( COPD ) real life set 8 week . Study Hypothesis : Primary interest give observe change baseline post-dose FEV1 8 week . Comparison ( ) : The objective observational study collect evaluate data bronchodilator efficacy safety Spiriva® ( 18 mcg tiotropium inhalation capsule ) deliver HandiHaler® , national sample Russian patient vary severity chronic obstructive pulmonary disease ( COPD ) real life set 8 week .</detailed_description>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>1 . 40 year old male female ambulatory outpatient see participate physician office routine care 2 . Patients previously treat Tiotropium 3 . Patients clinical diagnosis stage Chronic Obstructive Pulmonary Disease accord current National Guidelines / 2004 4 . Current smoker exsmokers smoke history &gt; =10 pack year 1 . Uncooperative patient judge physician , 2 . Patients condition , accord participate physicians opinion , might decrease chance obtain satisfactory data achieve objective observation , 3 . Patients history know preexist concomitant nonobstructive lung disease ( e.g. , sarcoidosis , tuberculosis , lung cancer ) , 4 . Patients currently enrol another clinical trial require change medication respiratory problem , 5 . Patients condition list special precaution , drug interaction , contraindication Spiriva® 's Russian package insert , : 6 . Patients know narrowangle glaucoma , 7 . Patients know symptomatic prostatic hypertrophy bladder neck obstruction , 8 . Patient known moderate severe renal impairment ( creatinine clearance le 50 ml/min ) , 9 . Patients history hypersensitivity atropine derivative , e.g . ipratropium oxitropium component product , 10 . Pregnant nursing woman .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>